Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities

Acute myeloid leukemias (AMLs) are hematologic malignancies with varied molecular and immunophenotypic profiles, making them difficult to diagnose and classify. High-dimensional analysis algorithms might increase the utility of multicolor flow cytometry for AML diagnosis and follow-up. The objective...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carmen-Mariana Aanei, Richard Veyrat-Masson, Cristina Selicean, Mirela Marian, Lauren Rigollet, Adrian Pavel Trifa, Ciprian Tomuleasa, Adrian Serban, Mohamad Cherry, Pascale Flandrin-Gresta, Emmanuelle Tavernier Tardy, Denis Guyotat, Lydia Campos Catafal
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/e2a5950c46fd43f79855962125a2e532
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:e2a5950c46fd43f79855962125a2e532
record_format dspace
spelling oai:doaj.org-article:e2a5950c46fd43f79855962125a2e5322021-11-05T06:20:28ZDatabase-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities2234-943X10.3389/fonc.2021.746951https://doaj.org/article/e2a5950c46fd43f79855962125a2e5322021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fonc.2021.746951/fullhttps://doaj.org/toc/2234-943XAcute myeloid leukemias (AMLs) are hematologic malignancies with varied molecular and immunophenotypic profiles, making them difficult to diagnose and classify. High-dimensional analysis algorithms might increase the utility of multicolor flow cytometry for AML diagnosis and follow-up. The objective of the present study was to assess whether a Compass database-guided analysis can be used to achieve rapid and accurate diagnoses. We conducted this study to determine whether this method could be employed to pilote the genetic and molecular tests and to objectively identify different-from-normal (DfN) patterns to improve measurable residual disease follow-up in AML. Three Compass databases were built using Infinicyt 2.0 software, including normal myeloid-committed hematopoietic precursors (n = 20) and AML blasts harboring the most frequent recurrent genetic abnormalities (n = 50). The diagnostic accuracy of the Compass database-guided analysis was evaluated in a prospective validation study (125 suspected AML patients). This method excluded AML associated with the following genetic abnormalities: t(8;21), t(15;17), inv(16), and KMT2A translocation, with 92% sensitivity [95% confidence interval (CI): 78.6%–98.3%] and a 98.5% negative predictive value (95% CI: 90.6%–99.8%). Our data showed that the Compass database-guided analysis could identify phenotypic differences between AML groups, representing a useful tool for the identification of DfN patterns.Carmen-Mariana AaneiRichard Veyrat-MassonCristina SeliceanCristina SeliceanMirela MarianLauren RigolletAdrian Pavel TrifaAdrian Pavel TrifaCiprian TomuleasaCiprian TomuleasaAdrian SerbanMohamad CherryPascale Flandrin-GrestaEmmanuelle Tavernier TardyDenis GuyotatLydia Campos CatafalFrontiers Media S.A.articleacute myeloid leukemia with recurrent genetic abnormalitiesmulticolor flow cytometryCompass database-guided analysisdifferent-from-normal (DfN) approachmeasurable (minimal) residual diseaseNeoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENFrontiers in Oncology, Vol 11 (2021)
institution DOAJ
collection DOAJ
language EN
topic acute myeloid leukemia with recurrent genetic abnormalities
multicolor flow cytometry
Compass database-guided analysis
different-from-normal (DfN) approach
measurable (minimal) residual disease
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle acute myeloid leukemia with recurrent genetic abnormalities
multicolor flow cytometry
Compass database-guided analysis
different-from-normal (DfN) approach
measurable (minimal) residual disease
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Carmen-Mariana Aanei
Richard Veyrat-Masson
Cristina Selicean
Cristina Selicean
Mirela Marian
Lauren Rigollet
Adrian Pavel Trifa
Adrian Pavel Trifa
Ciprian Tomuleasa
Ciprian Tomuleasa
Adrian Serban
Mohamad Cherry
Pascale Flandrin-Gresta
Emmanuelle Tavernier Tardy
Denis Guyotat
Lydia Campos Catafal
Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities
description Acute myeloid leukemias (AMLs) are hematologic malignancies with varied molecular and immunophenotypic profiles, making them difficult to diagnose and classify. High-dimensional analysis algorithms might increase the utility of multicolor flow cytometry for AML diagnosis and follow-up. The objective of the present study was to assess whether a Compass database-guided analysis can be used to achieve rapid and accurate diagnoses. We conducted this study to determine whether this method could be employed to pilote the genetic and molecular tests and to objectively identify different-from-normal (DfN) patterns to improve measurable residual disease follow-up in AML. Three Compass databases were built using Infinicyt 2.0 software, including normal myeloid-committed hematopoietic precursors (n = 20) and AML blasts harboring the most frequent recurrent genetic abnormalities (n = 50). The diagnostic accuracy of the Compass database-guided analysis was evaluated in a prospective validation study (125 suspected AML patients). This method excluded AML associated with the following genetic abnormalities: t(8;21), t(15;17), inv(16), and KMT2A translocation, with 92% sensitivity [95% confidence interval (CI): 78.6%–98.3%] and a 98.5% negative predictive value (95% CI: 90.6%–99.8%). Our data showed that the Compass database-guided analysis could identify phenotypic differences between AML groups, representing a useful tool for the identification of DfN patterns.
format article
author Carmen-Mariana Aanei
Richard Veyrat-Masson
Cristina Selicean
Cristina Selicean
Mirela Marian
Lauren Rigollet
Adrian Pavel Trifa
Adrian Pavel Trifa
Ciprian Tomuleasa
Ciprian Tomuleasa
Adrian Serban
Mohamad Cherry
Pascale Flandrin-Gresta
Emmanuelle Tavernier Tardy
Denis Guyotat
Lydia Campos Catafal
author_facet Carmen-Mariana Aanei
Richard Veyrat-Masson
Cristina Selicean
Cristina Selicean
Mirela Marian
Lauren Rigollet
Adrian Pavel Trifa
Adrian Pavel Trifa
Ciprian Tomuleasa
Ciprian Tomuleasa
Adrian Serban
Mohamad Cherry
Pascale Flandrin-Gresta
Emmanuelle Tavernier Tardy
Denis Guyotat
Lydia Campos Catafal
author_sort Carmen-Mariana Aanei
title Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities
title_short Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities
title_full Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities
title_fullStr Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities
title_full_unstemmed Database-Guided Analysis for Immunophenotypic Diagnosis and Follow-Up of Acute Myeloid Leukemia With Recurrent Genetic Abnormalities
title_sort database-guided analysis for immunophenotypic diagnosis and follow-up of acute myeloid leukemia with recurrent genetic abnormalities
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/e2a5950c46fd43f79855962125a2e532
work_keys_str_mv AT carmenmarianaaanei databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT richardveyratmasson databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT cristinaselicean databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT cristinaselicean databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT mirelamarian databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT laurenrigollet databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT adrianpaveltrifa databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT adrianpaveltrifa databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT cipriantomuleasa databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT cipriantomuleasa databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT adrianserban databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT mohamadcherry databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT pascaleflandringresta databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT emmanuelletaverniertardy databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT denisguyotat databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
AT lydiacamposcatafal databaseguidedanalysisforimmunophenotypicdiagnosisandfollowupofacutemyeloidleukemiawithrecurrentgeneticabnormalities
_version_ 1718444502739320832